Home
UNic™ Technology
Enhancing recombinant protein production across a range of eukaryotic production hosts, UNic™ results in more protein per mRNA.
UNic™ licenses are available for:
UNic™ increases recombinant protein production per cell in cultured mammalian cells as well as in yeast platforms. Improved production levels lead to better product economics.
Increasing enzyme production yields reduces manufacturing costs. Given the enzyme market dynamics, cost savings have a significant impact on profitability .
ProteoNic services are offered in support of UNic™ implementation or as general recombinant protein expression expertise for a range of commercial platforms.
- PHARMA
ProteoNic licenses its UNic™ technology for the production of antibodies and other biopharmaceutical proteins in cultured cells.
- INDUSTRIAL
Using UNic™ technology to manufacture industrial enzymes in fungal and yeast production strains, leads to significant cost savings.
- SERVICES
ProteoNic offers services in the field of recombinant protein production for various production hosts on a fee for service basis.